The open index of psychedelic research

Wayfinder Atlas: Global Psychedelic-Therapy Legality Tracker

Mayr, Sascha

Data from: 5-HT2ARs in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin

Jacob Baker, Emily Kogan, Shaorong Ma +2

Multiband ALFF in patients with major depressive disorder treated with esketamine and sertraline: A preliminary study.

Hua Z, Shu Y, Li L +8

Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.

Eun AC, Yang KH, Palamar JJ

SRP - Assessing behavior change in an on-going trial of psilocybin for MDD

Comparison of propofol fentanyl versus propofol ketamine for painless gastrointestinal endoscopy: a systematic review

Xiao S, Zhang J, Xiao S +1

Response to comment on "Hemodynamic and stress-modulating effects of adjuvant dexmedetomidine in esketamine-based anesthesia for laparoscopic hysterectomy: underappreciated neuroinflammatory regulation and unresolved long-term neurological safety issues".

Ye X, Xie B

Ketamine use in the refractory and super refractory status epilepticus: a systematic review

Troya-Córdova B, Pinto-Villalba R

Testing for Veridical Perception During Ketamine-Induced Out-of-Body States

Population-Stratified Distributions of Post-Mortem Blood Drug Concentrations: An Epidemiological Framework for Contextual Interpretation.

Algahtani T, Rock KL, Rice-Davies K +4

Psychedelics Restructure the Global Workspace of Consciousness

Yousefi P, Shinozuka K, Vizeli P +8

An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder

Tiwari P, Nayak SM, Sepeda ND +9

Dose-dependent modulation of visual imagery by Ayahuasca and dampening of visual processing away from external input: a placebo-controlled pharmacoimaging study

Castelo-Branco M, Gaidosch A, Teixeira M +6

Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled Trial

Kjellgren A, Lundberg J, Yngwe H +5

Ketamine Use Disorder and Entrenchment of Delusional Beliefs: A Case Report.

Yang SS, Goud R, Weleff J

Operationalizing Excellence in Psychedelic Care Through Advancing Competencies in Nurses: State-of-the Science Review.

Schimmels J, Nobbs M

Effects of ketamine infusion rate and cumulative dosing on incidence of delirium in medical intensive care unit patients.

Miller J, Johnson J, Laserna C +5

Low sexual desire in postpartum women: associations with psychosocial factors and sexual function.

Costa LFM, de Santana HCB, de Sousa Machado Júnior A +4

Serotonin biology as a basis for explaining psychedelic drug action

Knox C, Li-Wu A, Kwan A

Selective reductions amid global increases in neural information dynamics jointly track self-dissolution in meditation

Atad DA, Mediano PA, Trautwein F +6

The Meta-Awareness – Equanimity Framework of Self for Psychiatry: Phenomenological Insights from Psychosis and Mindfulness

Ganesan S, Lutz A, Zalesky A +2

Mind Perception as a Statistical Mediator between Psychedelic Experiences and Animal-Related Attitudes: A Differentiated Examination across Animal Categories

Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.

Du X, Peng F, Wang X

Alternative visions: The strategic partial medicalization of ibogaine treatment.

Lundgren J, Söderberg J